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细胞周期蛋白依赖性激酶 5（Cyclin-dependent kinase 5，Cdk5）是由脯氨酸
介导的丝氨酸/苏氨酸蛋白激酶，其在神经系统中发挥着重要的作用。Cdk5 的活
化主要靠神经系统中广泛表达的两个激活因子 p35 和 p39。Cdk5 对神经系统的
正常生理功能具有重要作用去，其可通过磷酸化众多底物的丝氨酸/苏氨酸位点，
在神经元的迁移分化，突触传递，轴突树突的发育过程以及神经元的存活中都发
挥着重要的作用。此外，在某些病理条件下，Calpain 所介导的 p35 切割形成 p25，
可以过度激活 Cdk5，诱导神经元凋亡和突触功能的紊乱，介导了多种神经退行
性疾病的发生发展，暗示着 Cdk5 很可能成为治疗神经退行性疾病的重要靶点。
在本文，我们重点阐述了 Cdk5 通过磷酸化 FOXO1 和 BAG3 在神经元存活和突
触功能的重要作用及其调控机制。 
在大脑的发育过程中，Cdk5 的缺失会导致神经元的死亡。氧化应激（H2O2）
和神经毒性（Aβ）的外界刺激下，p35 切割形成 p25，过度激活了 Cdk5，进而
诱导 Cdk5 可以磷酸化转录因子 FOXO1 的 Ser249 位点。FOXO1-Ser249 的磷酸






ERK 作为 MAPKs 家族的重要成员之一，其也可以参与调控 FOXO1。激活
的 ERK1/2 能够磷酸化 FOXO1，并提高 FOXO1的转录活性。而当加入 MEK的
抑制剂，其可抑制 FOXO1的转录活性，促进其降解，并抑制其下游靶基因的转
录表达。而 ERK对 FOXO1 的调控并不依赖 AKT。这就为我们深入了解 FOXO1
的功能提供了新的理论基础。 
除此之外，我们关注研究 Cdk5 的另一个全新的底物 BAG3，Cdk5 可以在体






















AMPA受体和 PSD95）的蛋白表达，而且通过染色发现 Synapsin 和 Synaptophysin

























Cyclin-dependent kinase 5 (Cdk5) is a multifaceted proline-directed serine or 
threonine kinase implicated to play pivotal roles in nervous system. Cdk5 two 
activator proteins p35 or p39 ubiquitously expressed in neuronal cells. In the 
physiological condition, Cdk5 plays vital roles in the CNS development by 
phosphorylating the specific serine or threonine site of numerous substrate proteins 
that are closely associated with the neuronal migration, synaptic transmission, axon 
and dendrite development as well as neuronal death and survival. Under pathological 
conditions, calpain-mediated cleavage of p35 into p25, which can consistently and 
strongly activate Cdk5, lead to neuronal death and synaptic dysfunction ultimately. 
Dysfunction of Cdk5 has been implicated in the pathogenesis of many 
neurodegenerative diseases, indicating that Cdk5 may be a potential target in the 
treatment of neurodegenerative diseases. In this thesis, we identified two novel 
substrates of Cdk5: FOXO1 and BAG3 and found that the regulation of Cdk5 on 
neuronal death and synaptic function may be through phosphorylating FOXO1 and 
BAG3. 
Deficiency of Cdk5 has been linked to the death of post-mitotic cortical neurons 
during brain development. We now report that, in mouse cortical neurons, Cdk5 is 
capable of phosphorylating the transcription factor FOXO1 at Ser249 in vitro and in 
vivo. Cellular stresses resulting from extracellular stimulation by H2O2 or 
β-amyloid promote hyperactivation of Cdk5, FOXO1 nuclear export and inhibition 
of its downstream transcriptional activity. In contrast, a loss of Cdk5 leads to 
FOXO1 translocation into the nucleus: a shift due to decreased AKT activity but 
independent of Ser249 phosphorylation. Nuclear FOXO1 upregulates transcription 
of the proapoptotic gene, BIM, leading to neuronal death, which can be rescued 
when endogenous FOXO1 was replaced by the cytoplasmically localized form of 
















death by inhibiting FOXO1 transcriptional activity and BIM expression. Together, 
our findings suggest that Cdk5 plays a novel and unexpected role in the degeneration 
of postmitotic neurons through modulation of the cellular location of FOXO1, which 
constitutes an alternative pathway through which Cdk5 deficiency leads to neuronal 
death. 
At the meantime, we also found that the activation of ERK1/2 can induced the 
transcriptional activity of FOXO1 via phosphorylation. The administration of MEK 
inhibitors which suppressed ERK activity dramatically decrease FOXO1 activity, 
and facilitate its degeneration. We also demonstrated that this process is independent 
of AKT activity. These results suggested that FOXO1 is specifically phosphorylated 
by ERK and Cdk5, which provides a new insight in the functional regulation of 
FOXO1. 
Besides FOXO1, we identified synaptic protein BAG3 as another new Cdk5 
substrate. Cdk5 can phosphorylate BAG3 at Ser291 in vitro and in vivo. Furthermore, 
BAG domain of BAG3 mediates the interaction between Bag3 with Cdk5 activator 
protein p25. Even Bag3 was reported to be located in synapsis, the underly function 
of BAG3 in synaptic function is unknown. To explore this issue, we performed 
AAV2/8-shbag3 intracerevroventricular (ICV) injection on neonatal day P0 to 
downregulate BAG3 in mice brain. After virous injection, we found that the neuronal 
dendritic spines were dramatically loss in hippocampal CA1 and cortical regions. 
Given that AAV2/8-shbag3 injected mice exhibited significant synaptic deficits, we 
next investigated the animal behaviors and found that knockdown BAG3 resulted in 
significant cognitive impairment and memory deficits. Further studies show that 
significant reduction of pre-synaptic (synaptophysin and synapsin) and post-synaptic 
(NMDA receptor, AMPA receptor and PSD95) proteins in BAG3-knockdown 
neurons. Our results defined a critical pathway in which decreased BAG3-mediated 
synaptic dysfunction and memory impairments 
Our findings provided solid data supported that Cdk5 is critical for synaptic 
function and neuronal death through phosphorylation FOXO1 and BAG3. These 
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英文缩写 英文全名 中文名称 
AD Alzheimer's disease 阿尔茨海默症 
PD Parkinson's disease 帕金森病 
HD Huntington's disease 亨廷顿疾病 
ALS Amyotrophic  lateral sclerosis 肌萎缩侧索硬化症 
A-T Ataxia-Telangiectasia 毛细血管扩张综合症 
NFT Neurofibrillar Tangles 神经元纤维缠结 
Aβ β-amyloid β-淀粉样蛋白 
Bcl-2 B-cell lymphoma/ leukemia-2 B-细胞淋巴瘤/白血病-2 
Cdk1 Cyclin-dependent kinase 1 细胞周期依赖性蛋白激酶 1 
Cdk2 Cyclin-dependent kinase 2 细胞周期依赖性蛋白激酶 2 
Cdk3 Cyclin-dependent kinase 3 细胞周期依赖性蛋白激酶 3 
Cdk4 Cyclin-dependent kinase 4 细胞周期依赖性蛋白激酶 4 
Cdk5 Cyclin-dependent kinase 5 细胞周期依赖性蛋白激酶 5 
Cdk6 Cyclin-dependent kinase 6 细胞周期依赖性蛋白激酶 6 
BAG3 Bcl2-associated athanogene 3 Bcl2 相关抗凋亡基因 3 
FOXO1 Fork head box O1 插头转录因子 O亚家族蛋白 1 
AAV Adeno-associated virus 腺相关病毒 
LPS Lipopolysaccharide 脂多糖 
PI3K Class III phosphatidylinositol 3-kinase III型磷脂酰肌醇-3激酶 
NMDA N-methyl-D-aspartic acid N-甲基-D-天冬氨酸 
NO Nitrogen monoxide 一氧化氮 
MEF2 Myocyte Enhancer Factor 2 肌细胞增强因子 2 
TSC1/2 Tuberous sclerosis complex 1/2 结节性硬化症复合物 1/2 
CaMKKB calmodulin-dependent kinase kinase-β Ca2+/钙调蛋白激酶 
AMPK AMP-activated protein kinase AMP 激活的蛋白激酶 
ERK1/2 Extracellular signal-regulated kinase 1/2 细胞外信号调节蛋白激酶 1/2 
GSK-3β Glycogen synthase kinase 3 beta 糖原合成激酶 3 beta 
ATM Ataxia-telangiec mutatedgene 毛细血管扩张共济失调突变基因 
NLS Nuclear localization signal  核定位信号肽 
NES Nuclear Expot signal 核输出信号肽 
MST1 Manmnlian ste-20-like kinase 无 
MDM2 Murine double minute 2 泛素蛋白连接酶 MDM2 
CNS Central nervous system 中枢神经系统 
NFAT Nuclear factor of activated T-cells T 细胞核因子 
JNK c-Jun N-terminal kinases c-Jun 氨基末端激酶 
MAPKs Mitogen-activated protein kinases 丝裂原活化蛋白激酶 
CASA Chaperone-assisted selective autophagy 分子伴侣相关选择性自噬 
PKB Protein kinase B 蛋白激酶 B 
PDK1 3-phosphoinositide-dependent protein 
kinase-1 
3-磷酸肌醇依赖性蛋白激酶-1 
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